BCI
DGX icon

Brinker Capital Investments’s Quest Diagnostics DGX Stock Holding History

Brinker Capital Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Sell
9,417
-335
-3% -$65.7K 0.02% 799
2026
Q1 		$1.91M Buy
9,752
+195
+2% +$37.9K 0.02% 779
2025
Q4 		$1.66M Sell
9,557
-4,410
-32% -$803K 0.01% 954
2025
Q3 		$2.66M Sell
13,967
-2,368
-14% -$420K 0.02% 686
2025
Q2 		$2.93M Sell
16,335
-4,239
-21% -$736K 0.03% 599
2025
Q1 		$3.48M Sell
20,574
-288
-1% -$47.3K 0.03% 473
2024
Q4 		$3.15M Buy
20,862
+1,125
+6% +$175K 0.03% 488
2024
Q3 		$3.06M Buy
19,737
+3,837
+24% +$573K 0.03% 494
2024
Q2 		$2.18M Sell
15,900
-560
-3% -$76.7K 0.02% 614
2024
Q1 		$2.19M Sell
16,460
-3,184
-16% -$413K 0.02% 622
2023
Q4 		$2.78M Sell
19,644
-1,237
-6% -$163K 0.03% 476
2023
Q3 		$2.54M Sell
20,881
-692
-3% -$92.2K 0.03% 511
2023
Q2 		$3.03M Buy
21,573
+13,061
+153% +$1.8M 0.03% 482
2023
Q1 		$1.2M Sell
8,512
-224
-3% -$32K 0.01% 805
2022
Q4 		$1.37M Sell
8,736
-372
-4% -$53.5K 0.03% 618
2022
Q3 		$1.12M Sell
9,108
-85
-0.9% -$11.2K 0.02% 669
2022
Q2 		$1.22M Sell
9,193
-18,058
-66% -$2.46M 0.02% 662
2022
Q1 		$3.73M Buy
27,251
+17,300
+174% +$2.41M 0.06% 315
2021
Q4 		$1.72M Sell
9,951
-571
-5% -$86.9K 0.03% 629
2021
Q3 		$1.39M Hold
10,522
– – 0.02% 656
2021
Q2 		$1.39M Sell
10,522
-3,177
-23% -$416K 0.02% 712
2021
Q1 		$1.76M Sell
13,699
-6,925
-34% -$853K 0.03% 546
2020
Q4 		$2.46M Buy
20,624
+5,884
+40% +$717K 0.04% 506
2020
Q3 		$1.69M Buy
+14,740
New +$1.74M 0.03% 527
2019
Q3 		– Sell
-61
Closed -$6K – 786
2019
Q2 		$6K Hold
61
– – ﹤0.01% 823
2019
Q1 		$5K Buy
+61
New +$5.29K ﹤0.01% 704
2017
Q4 		– Sell
-35
Closed -$3K – 527
2017
Q3 		$3K Buy
+35
New +$3.72K ﹤0.01% 522

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Brinker Capital Investments's DGX Position: Q2 2026 in Review

Brinker Capital Investments reduced its Quest Diagnostics (DGX) stake by 3.4% in Q2 2026, selling an estimated $65.7K and leaving 9,417 shares worth $2M. The position accounts for 0.02% of the portfolio, ranked #799.

Brinker Capital Investments first reported a position in DGX in Q3 2017 and has held it in 27 quarters since. The position peaked at $3.73M in Q1 2022. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Brinker Capital Investments held 9,417 shares of Quest Diagnostics worth $2M as of Q2 2026.
  • Brinker Capital Investments sold 335 Quest Diagnostics shares in Q2 2026, an estimated $65.7K.
  • Quest Diagnostics made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #799 holding.
  • Brinker Capital Investments first reported a position in Quest Diagnostics in Q3 2017 and has held it in 27 quarters since.
  • Brinker Capital Investments's Quest Diagnostics position peaked at $3.73M in Q1 2022.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.